OOIR: Observatory of International Research

Papers

(The median citation count of Scandinavian Journal of Urology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Predictors for complication in renal cancer surgery: a national register study	47
Urinary stone assessment in a single-phase may replace the unenhanced and multiphase computed tomography protocol in painless visible haematuria	27
Taking the temperature: a case of urethral polyembolokoilamania	25
Transurethral versus open enucleation of the prostate in Sweden – a retrospective comparative cohort study	23
Kidney tumor biopsy – an unmet need for personalized treatment	21
Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study	17
Early and late surgical complications following living donor nephrectomy	16
Biochemical recurrence after radical prostatectomy – a large, comprehensive, population-based study with long follow-up	14
Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990–2019	12
Community-onset urosepsis: incidence and risk factors for 30-day mortality – a retrospective cohort study	11
Prediction of clinically significant recurrence after partial nephrectomy. Data from the Cancer Registry of Norway with more than five years of follow-up	10
Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma	10
UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice – from biobank to RNA-sequencing in real time	10
Welcome to the new Scandinavian Journal of Urology!	9
Abandoning testing for asymptomatic microscopic haematuria in Sweden – a long-term follow-up	9
Prospective validation study of a combined urine and plasma test for predicting high-grade prostate cancer in biopsy naïve men	9
A new important tool to report and analyse adverse incidents that all urologists should use Editorial comment to: Nisen H, Erkkilä K, Ettala O, Ronkainen H, et al. Intraoperative complications in kidn	8
Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational s	7
The Swedish prostate cancer guidelines: response to Axcrona and Löffeler	7
Evaluation of the relation between size of stone and its attenuation measured by Hounsfield units and the total laser energy required to fragment it	7
Impact of ischemia time during partial nephrectomy on short- and long-term renal function	7
Surgeon volume and patient-reported urinary incontinence after radical prostatectomy. Population-based register study in Sweden	7
Recurrence of non-muscle invasive bladder carcinoma after transurethral resection with hexaminolevulinate photodynamic diagnosis or regular cystoscopy	7
Surgical experience is predictive for bladder tumour resection quality	7
S-phase – an independent prognostic marker in upper tract urothelial carcinoma	6

A population-based registry cohort study on the correlation between bladder-intact event-free survival and overall survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in	6
Quadratus lumborum block is feasible alternative to epidural block for postoperative analgesia after open radical cystectomy: surgical and oncological outcomes of a randomised clinical trial	6
Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide population-based study	6
Temperature profiles during ureteroscopy with thulium fiber laser and holmium:YAG laser: Findings from a pre-clinical study	6
Evaluation of data quality in the Swedish National Penile Cancer Register	5
How to survey adherence to guidelines by use of clinical cancer registers	5
Swedish national guidelines on urothelial carcinoma: 2024 update on advanced and metastatic disease	5
The effect of povidone-iodine rectal cleansing on post-biopsy infectious complications	5
The clinical consequences of routine ⁶⁸Ga-PSMA-11 PET/CT in patients with newly diagnosed prostate cancer, ISUP grade 5 and no metastases based on standard imaging – preliminary results	5
Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis	5
How to improve cancer care by use of guidelines and quality registers	4
Triggers for transition from active surveillance to radical treatment of prostate cancer 2008–2020 – a case-control study	4
Cutaneous adverse reactions associated to apalumide: two case reports of DRESS syndrome and maculopapular exanthema	4
Assessment of complications after transperineal and transrectal prostate biopsy using a risk-stratified pathway identifying patients at risk for post-biopsy infections	4
Validation of a Swedish version of the National Institute of Health – Chronic Prostatitis Symptom Index	4
Salvage HDR brachytherapy for prostate cancer: a high-volume center experience on 100 consecutive patients	4
First diagnostic results from Gothenburg-2 screening trial	4
Exercise in primary care after robot-assisted radical cystectomy for urinary bladder cancer – effects on postoperative complications: a secondary analysis of a randomised controlled trial	4
Incidence of erectile dysfunction treatment after radical prostatectomy by Statin use in Finnish Nationwide Cohort Study	4
External validation of a simplified prognostic model for survival in patients with extrinsic malignant ureteral obstruction treated with tandem ureteral stents – a retrospective cohort study	4
A Norwegian perspective on the Swedish national guidelines on prostate cancer for non-metastatic disease	3
Primary and revision artificial urinary sphincter for stress urinary incontinence post-radical prostatectomy: a surgery with high rewards but high risks?	3
The association between age and long-term quality of life after curative treatment for prostate cancer: a cross-sectional study	3
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway	3
Computed tomography for visible haematuria – a single nephrographic phase is sufficient for detecting renal cell carcinoma	3
Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?	3
The Stockholm Spinal Cord Uro Study: Changing patterns of urological surgery in a regional prevalence group through 50 years – Outcomes and lessons learned	3
Patient-reported long-term sexual morbidity in prostate cancer survivors treated with external beam radiation therapy alone or combined with high-dose-rate brachytherapy	3
Minimising warm ischaemia time during robot-assisted partial nephrectomy. A video-based assessment of tumour excision, kidney reconstruction and intermediate time	3
Don’t throw out the baby with the bath water!	3
Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study	3
Anorectal function and symptoms 6 months after robot-assisted laparoscopic radical prostatectomy: a single-center study	3
Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk	3
Assessment of variability in life expectancy in older men by use of new comorbidity indices. A nationwide population-based study	3
Do men adapt to lower urinary tract symptoms? An 11-year longitudinal study of male urinary urgency and associated bother	3
Abstract book for the 34th Congress of the Scandinavian Association of Urology (NUF)	3
The pursuit of excellence	2
Lower urinary tract injuries in patients with pelvic fractures at a level 1 trauma center – an 11-year experience	2
Robot-assisted nephroureterectomy for upper tract urothelial carcinoma—feasibility and complications: a single center experience	2
The difficulty of studying the association between pathway delays and survival in cancer – an example from bladder cancer	2
Thermo-expandable intraprostatic nitinol stents in the treatment of bladder outlet obstruction: a consecutive case series	2
Paediatric percutaneous nephrolithotomy (P-PCNL) reporting checklist	2
Isolated monkeypox genital lesions	2
Violation of onco-surgical principles is associated with survival outcomes in upper tract urothelial carcinomas after radical nephroureterectomy	2
First population-level results of pre-biopsy prostate MRI	2
Healthcare costs in relation to increased use of preoperative renal tumour biopsies	2
Current evidence for moderate and ultra-hypofractionated radiation therapy in prostate cancer: a summary of the results from phase 3 randomised trials	2
Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019	2
Health-related quality of life prior to and 1 year after radical cystectomy evaluated with FACT-G and FACT-VCI questionnaires	2
Long-term efficacy of selective arterial embolisation of renal angiomyolipoma	2

Normalised repeat serum prostate-specific antigen: associations with age and magnetic resonance imaging results	2
Urosymphyseal fistula after pelvic radiotherapy in a tertial referral centre – a rare entity with significant comorbidity requiring multidisciplinary management	2
Bladder cancer with secondary muscle invasion – a prognostic dilemma	2
Transurethral microwave thermotherapy with the CoreTherm®Concept in men with prostates larger than 100 grams – a consecutive case series	2
A randomised study of TURP after intraprostatic injection of mepicacaine/adrenaline versus regular TURP in patients with LUTS/BPO	2
The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant disease	2
Zoster sine herpete causing voiding disorders in females	2
Onset of androgen deprivation therapy leads to rapid deterioration of body composition, physical performance, cardiometabolic health and quality-of-life in prostate cancer patients	2